Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Return to: PBR Home | Production & Manufacturing
Today in Production & Manufacturing

Production & Manufacturing

Mylan launches generic Concerta tablets in US for ADHD treatment Mylan has launched a generic version of Janssen's Concerta tablets in the US, after receiving approval from the local authorities. News

Latest Production & Manufacturing News by Sector

Select a sector from the list or browse by sector below:

Fine & Speciality Chemicals

Bayer plans to focus entirely on Life Science businesses
Bayer intends in the future to focus entirely on the Life Science businesses – HealthCare and CropScience – and float MaterialScience on the stock market as a separate company. In this way Bayer is positioning itself as a world-leading company in the field of human, animal and plant health.
Production & Manufacturing > Fine & Speciality Chemicals > News
CordenPharma agrees to purchase Peptisyntha from Solvay
By PBR Staff Writer
International Chemical Investors Group (ICIG) and the Solvay Group have embarked on an agreement, whereby ICIG will purchase Belgium-based Peptisyntha SA, a custom manufacturer of peptides for pharmaceutical use.
Production & Manufacturing > Fine & Speciality Chemicals > News

Process & Production

FDA extends review period by three months for rheumatoid arthritis candidate baricitinib
By PBR Staff Writer
The US Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) goal date by three months for investigational rheumatoid arthritis treatment, Baricitinib.
Production & Manufacturing > Process & Production > News
Heron submits CINVANTI NDA to FDA for CINV prevention
Heron Therapeutics has submitted its New Drug Application (NDA) to the US Food and Drug Administration (FDA) for CINVANTI (HTX-019), a polysorbate 80-free, intravenous formulation of aprepitant for the prevention of Chemotherapy-Induced Nausea and Vomiting (CINV).
Production & Manufacturing > Process & Production > News

OTC

Valeant Pharmaceuticals agrees to divest $2.1bn in assets
By PBR Staff Writer
Valeant Pharmaceuticals International has agreed to sell about $2.1bn in assets as it seeks to reduce over $30bn in debt.
Production & Manufacturing > OTC > News
FDA approves Perrigo's generic Nicorette White Ice Mint Gum
Perrigo has secured approvals from the US Food and Drug Administration for abbreviated new drug applications referencing GlaxoSmithKline's Nicorette White Ice Mint Gum (nicotine polacrilex gum 2 mg and 4 mg).
Production & Manufacturing > OTC > News

Manufacturing

US appeals court upholds Eli Lilly's patent on Alimta cancer drug
By PBR Staff Writer
Eli Lilly and Company has received a favorable court ruling in the US regarding the vitamin regimen patent for its cancer drug Alimta.
Production & Manufacturing > Manufacturing > News
Takeda to buy Ariad Pharmaceuticals for $5.2bn
By PBR Staff Writer
Japan's Takeda Pharmaceutical has agreed to acquire US cancer drug maker Ariad Pharmaceuticals in a transaction worth about $5.2bn.
Production & Manufacturing > Manufacturing > News